We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > acne vulgaris

News List

FDA Approves Twyneo (tretinoin and benzoyl peroxide) for the Treatment of Acne Vulgaris drugs
July 28, 2021
Sol-Gel Technologies, Ltd. today announced that FDA has approved its first proprietary drug product, Twyneo cream, 0.1%/3%, indicated for the treatment of acne vulgaris in adults and pediatric patients nine years of age and older.
Kintor Pharmaceuticals Announced Successful Dosing of the First Batch of Patients for Acne Vulgaris Phase I/II Clinical Trial of Pyrilutamide prnasia
April 19, 2021
Kintor Pharmaceutical Limited, a clinical-stage biotechnology company developing small molecule and biological therapeutics, announced the clinical trial of Pyrilutamide as a treatment for the acne vulgaris has completed the first batch of patients ...
Aleor Dermaceuticals gets US FDA nod for Adapalene Gel USP expresspharma
June 22, 2020
It is indicated for the topical treatment of acne vulgaris in patients 12 years of age and older.